Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The external reviewer will evaluate your complete medical record, the clinical evidence supporting GLP-1 use, and whether Anthem applied their own coverage criteria correctly
Its protective effects on healthy cells and tissues may improve the tolerability and effectiveness of chemotherapy
Why Rochester-Area Residents Trust Vital Health Medical Care Rochester, New York, is a community with a strong tradition of medical excellence, anchored by institutions like the University of Rochester Medical Center and Rochester Regional Health
You may be a good candidate for Zepbound treatment if: Your BMI is 30 or higher, or Your BMI is 27 or higher with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol) If your BMI is under 27, you may still be a candidate to be prescribed Zepbound, depending on your medical history, lab results, or previous use of the medications
Semaglutide, a GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Ozempic) and chronic weight management (Wegovy), works through mechanisms that overlap with the physiological changes produced by sleeve gastrectomy
US$ 21.41
US$ 26.32
US$ 25.36
US$ 25.78
US$ 20.62
US$ 29.45
US$ 22.21
